Healthcare - Page 7 | TalkMarkets
All Posts > Content under Healthcare
97 to 112 of 584 Posts
<<< 1 ... 5 6 7 8 9 ... 37 >>>
A Recap Of My MannKind Experience
Article By: Trevor Lowenthal
Friday, October 3, 2014 3:31 AM EDT
Various commentators questioned my integrity and motives for my continued coverage of MannKind. This article hopes to set the record straight.
In this article: MNKD
Read
Healthcare Review: FHCO, GOVX, HTBX, ARIA, INCY
Article By: BioMedReports
Thursday, October 2, 2014 3:38 PM EDT
US stocks fluctuated amid an unexpected decline in jobless claims, while European equities plunged and the euro rose on concern additional stimulus will fail to boost inflation and revive the economy.
In this article: NVS, PFE, GOVX, ARIA, INCY, FHCO, HTBX
Read
Bull Of The Day: Acadia Healthcare
Article By: Kevin Cook
Thursday, October 2, 2014 11:56 AM EDT
The company exceeded expectations, including a 23% increase in year-over-year EPS on a 20% boost to the top line and an 11.5% jump in same-facility revenue.
In this article: ACHC
Read
Akebia Therapeutics: A Trade Opportunity With A Catalyst Ahead?
Article By: M.E. Garza
Thursday, October 2, 2014 9:26 AM EDT
With shares trading within a technical range and an upcoming catalyst ahead, it may be time to look for a trade opportunity via Akebia Therapeutics.
In this article: AKBA
Read
Sure Bets: Slow Changing Industries For Long-Term Investors
Article By: SureDividend
Wednesday, October 1, 2014 5:32 PM EDT
Find out what industries change slowly enough to allow the dominant players in the industry to compound wealth year after year.
In this article: ABT, AFL, CB, JNJ, KO, MCD, PEP
Read
Healthcare Review: CPRX, CANF, ACST, NWBO, ACT
Article By: BioMedReports
Wednesday, October 1, 2014 3:35 AM EDT
The Dow Jones Industrial Average rose 37 points, or 0.2%, to 17108. The S&P 500 added four points, or 0.2%, to 1982, and the Nasdaq Composite Index rose six points, or 0.1%, to 4512.
In this article: NWBO, ACST, CPRX, ACT, CANF
Read
Clovis Oncology Should Not Be Ignored
Article By: Terry Chrisomalis
Tuesday, September 30, 2014 6:10 PM EDT
Clovis announces positive Phase 2 results In Ovarian Cancer patients
In this article: CLVS
Read
Healthcare Review: CLVS, CBAY, PVCT, TNXP, SGEN
Article By: BioMedReports
Monday, September 29, 2014 5:50 PM EDT
Global equity markets fell on Monday as civil unrest in Hong Kong weighed on investor sentiment, while U.S. Treasury debt prices rose over uncertainty sparked by the protests.
In this article: PVCT, TNXP, SGEN, CLVS, CBAY
Read
Ebola Vs. Us
Article By: Ilene Carrie
Sunday, September 28, 2014 6:55 PM EDT
Ebola is spreading too quickly for Ebola-vaccine makers to conduct typical studies of safety and efficacy on experimental vaccines. Instead, vaccines will be deployed with protocols devised now, as the situation is worsening daily.
In this article: GSK, NLNK
Read
BioLife Elevates Guidance With 130 Embedded Clinical Trials
Article By: Trevor Lowenthal
Sunday, September 28, 2014 4:48 PM EDT
Overall, I calculate that BioLife is now supported to generate approximately $23 million in revenue by 2018.
In this article: BLFS
Read
10 E-Commerce Startups You Should Keep An Eye On
Article By: Geektime
Saturday, September 27, 2014 6:15 PM EDT
A more mature web economy requires an army of smaller companies to keep it humming along.
In this article: ASOMY, CRCM
Read
Webinar: Trade Like It's A Business
Video By: Ernie Varitimos
Friday, September 26, 2014 12:00 PM EDT
Trading success can depend on a number of different variables, just like any business. It's time to treat it like one.
Watch
Healthcare Review: IG, ABBV, ECTE, RNN, OFIX
Article By: BioMedReports
Thursday, September 25, 2014 5:03 PM EDT
The S&P 500 fell 29 points, or 1.5%, to 1969. The Nasdaq NDAQ -1.61% Composite Index declined 83 points, or 1.8%, to 4472.
In this article: IG, RNN, ECTE, OFIX, ABBV
Read
Healthcare Review: ELMD, EGLT, ECTE, ATOS, CBMX
Article By: BioMedReports
Thursday, September 25, 2014 3:16 AM EDT
The Dow Jones Industrial Average gained 102 points, or 0.6%, to 17158. The S&P 500 index added 10 points, or 0.5%, to 1993 and the Nasdaq Composite rose 34 points, or 0.8%, to 4543.
In this article: ECTE, CBMX, ELMD, EGLT, ATOS
Read
Inovio Pharma Wants To Join The Ebola Party
Article By: Terry Chrisomalis
Wednesday, September 24, 2014 10:33 PM EDT
Inovio Pharmaceuticals To Begin Ebola Vaccine Study in early 2015
In this article: INO, TKMR
Read
Healthcare Review: GENE, PGNX, RPRX, TKMR, THLD
Article By: BioMedReports
Wednesday, September 24, 2014 12:30 PM EDT
U.S. stocks fell on Monday, with the Dow Jones Industrial Average stepping back from an all-time high, as uncertainty about China's growth injected caution into global markets.
In this article: GENE, PGNX, RPRX, TKMR, THLD
Read
97 to 112 of 584 Posts
<<< 1 ... 5 6 7 8 9 ... 37 >>>